The USP Performance Test Dissolution Systems Suitability Studies Walter W. Hauck, Ph.D. USP Consultant Presentation to Advisory Committee for Pharmaceutical.

Slides:



Advertisements
Similar presentations
CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
Advertisements

Dr. Birgit Schmauser, BfArM, Bonn
Analytical Method Development and Validation
USP and Dissolution Testing Advisory Committee for Pharmaceutical Sciences 2 May 2005 Will Brown Staff Liaison to the Biopharmaceutics Expert Committee.
Statistical Approaches to Addressing the Requirements of the New FDA Process Validation Guidance for Small Molecules 1 Jason Marlin, MS/T Statistics, Eli.
Charles Y. Tan, PhD USP Statistics Expert Committee
1 Dissolution Measurement System: Current State and Opportunities for Improvement Dr. Lucinda Buhse Director, Division of Pharmaceutical Analysis.
Mitigating Risk of Out-of-Specification Results During Stability Testing of Biopharmaceutical Products Jeff Gardner Principal Consultant 36 th Annual Midwest.
World Health Organization
Measuring and Managing Method Variability
PHARM 462 PART / /31 Good Manufacturing Practices (GMP) VALIDATION of ANALYTICAL TEST METHODS.
World Health Organization
Chapter 10 Quality Control McGraw-Hill/Irwin
Selection of measuring instruments
Chapter 10 Quality Control McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
Statistical Process Control
Quality Assurance.
A Statistical Approach to Method Validation and Out of Specification Data.
Quality control of raw materials In-process control
Chapter 11 Quality Control.
Short Course on Introduction to Meteorological Instrumentation and Observations Techniques QA and QC Procedures Short Course on Introduction to Meteorological.
Probability and Statistics in Engineering Philip Bedient, Ph.D.
Inter-Laboratory Method Transfer
Technical requirements  Sampling  Analysis  Reporting of the results.
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Validation of Analytical Methods Used For Bioequivalence.
Unit #7 - Basic Quality Control for the Clinical Laboratory
Codex Guidelines for the Application of HACCP
Quality Assurance.
Quality Assessment 2 Quality Control.
World Health Organization
Validation of Analytical Method
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
The following minimum specified ranges should be considered: Drug substance or a finished (drug) product 80 to 120 % of the test concentration Content.
Establishing Drug release/Dissolution Specifications – QBD Approach Moheb M. Nasr, Ph.D. Office of New Drug Quality Assessment (ONDQA), OPS, CDER Advisory.
Analyzing Reliability and Validity in Outcomes Assessment (Part 1) Robert W. Lingard and Deborah K. van Alphen California State University, Northridge.
Analytical considerations
Analysis and Visualization Approaches to Assess UDU Capability Presented at MBSW May 2015 Jeff Hofer, Adam Rauk 1.
Analytical considerations in the dissolution testing of oral modified release products Graham Clarke Bristol-Myers Squibb Moreton, UK The British Pharmaceutical.
QUALITY ASSURANCE IN THE SALT INDUSTRY BY BRIAN T DANGERFIELD.
Important informations
1 Handling Uncertainty in the Development and Design of Chemical Processes David Bogle, David Johnson and Sujan Balendra Centre for Process Systems Engineering.
<701> DISINTEGRATION
Bureau of Drug and Narcotic Mechanical Calibration Temperature control  Calibrated thermometer  ˚ C Distance between the inside bottom of the.
Why do we need to do it? What are the basic tools?
1 Is it potent? Can these results tell me? Statistics for assays Ann Yellowlees PhD Quantics Consulting Limited.
1 Exercise 7: Accuracy and precision. 2 Origin of the error : Accuracy and precision Systematic (not random) –bias –impossible to be corrected  accuracy.
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Wenclawiak, B.: Fit for Purpose – A Customers View© Springer-Verlag Berlin Heidelberg 2003 In: Wenclawiak, Koch, Hadjicostas (eds.) Quality Assurance in.
In the name of Allah,the Most Beneficient, Presented by Nudrat Rehman Roll#
Quality Control Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill.
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
EQUIPMENT and METHOD VALIDATION
Diagnostic clinical chemistry
Establishing by the laboratory of the functional requirements for uncertainty of measurements of each examination procedure Ioannis Sitaras.
Dissolution Test (U.S.P.): Two set of apparatus: Apparatus-1: A single tablet is placed in a small wire mesh basket attached to the bottom of the shaft.
Quality is a Lousy Idea-
Level - 3 Process Areas (CMMI-DEV)
Practical clinical chemistry
Quality is a Lousy Idea-
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
Analytical Method Validation
USP and Dissolution Testing
Topics in Microbiology Quality Assurance Project Plan Essentials
METHOD VALIDATION: AN ESSENTIAL COMPONENT OF THE MEASUREMENT PROCESS
USP and Dissolution Testing
Chapter 11 Quality Control.
Quality Control Lecture 3
Quality Assessment The goal of laboratory analysis is to provide the accurate, reliable and timeliness result Quality assurance The overall program that.
Presentation transcript:

The USP Performance Test Dissolution Systems Suitability Studies Walter W. Hauck, Ph.D. USP Consultant Presentation to Advisory Committee for Pharmaceutical Sciences October 25, 2005

Topics  Systems Suitability Studies for Dissolution  Collaborative Study Design and Analysis  Variances: Correction to May 2005 Discussion  Next Steps

System Suitability  USP and ICH Q2b: … to ensure that the validity of the analytical method is maintained whenever used. Typical variations are the stability of the analytical solutions, equipment, and analysts. … System suitability tests are based on the concept that the equipment, electronics, analytic operations, and samples to be analyzed constitute an integral system that can be evaluated as such.

Types of Dissolution Systems Suitability Studies  Chemical Calibration  The term is a misnomer—it is a periodic Systems Suitability or system verification study  USP calibrator tablets support this type of study  The approach evaluates the system as a whole (apparatus plus operator plus procedures)  Acceptance ranges for dissolution values of the calibrator tablets determined by collaborative studies for each new lot (e.g., new Prednisone Lot P)  Other Approaches  Mechanical Calibration  Engineering Approaches

Terminology  Apparatus  One vessel  One stirring element  One position in the assembly  Assembly  One motor  Same temperature controller  Multiple apparatuses (6 or more)  Also called ‘bath’  Experiment  Single units tested in all apparatuses in the assembly (in the collaborative study, n= 6)

Systems Suitability: Chemical Calibration  Calibration procedure  For assembly under study, use standard dissolution procedure; test all apparatuses in the assembly  Assembly/apparatus must be mechanically calibrated  Acceptance applied to each position (apparatus) If one position result is unacceptable then entire assembly is also unacceptable Increased risk of failing due to multiple testing  Evaluates the integrated function of the system to prepare a dissolution sample

Systems Suitability: Mechanical Calibration  If a mechanical system is properly aligned and conforms to tolerances established for all such systems, then the operation of the system should be suitable  Dissolution test apparatus and assembly are mechanical systems  If mechanical calibration is the only control, no further check on the system is performed and system is assumed to be suitable

Systems Suitability: Mechanical Calibration  Deficiency of purely mechanical calibration  Assumes that the integrated system is no more than the sum of its parts  Does not evaluate that standard flow of medium is achieved  Limited understanding of the appropriate range and measurement mode for vibration  Difficulty of determining that vessel is suitable (surface irregularity, deviation from hemisphere and cylinder) List of suggested improved mechanical tolerances in Dissolution Calibration: Recommendations for Reduced Chemical Testing and Enhanced Mechanical Calibration, PhRMA Dissolution Calibration Subcommittee, PF 26(4) [July-Aug. 2000]

Topics  Systems Suitability Studies for Dissolution  Collaborative Study Design and Analysis  Variances: Correction to May 2005 Discussion  Next Steps

Collaborative Study Design  Standard product (tablet)  Standard procedures employed  Determine range of results from mechanically-calibrated assemblies  Determine bounds for “acceptable” results  collaborating laboratories, international

Design Evolution  Originally, each lab performed one experiment per condition (e.g., basket at 50 rpm)  Beginning with 2003, each lab performs two experiments per condition with separate operator and equipment;  Allows separation of inter-laboratory and intra-laboratory (intermediate) precision

Analysis Considerations  Analysis is preceded by a control chart analysis to select labs/experiments for inclusion in determination of acceptance ranges  Follows what had been PhRMA procedure  Statistical analysis determines three variances –  apparatus/tablet/assay  between-experiment, with-in laboratory  between-laboratory

Sample Xbar and S Control Charts for Apparatus 2, 30 Minutes

Representative CV’s (%) CV total CV between -lab CV within -lab CV between + within- lab CV apparatus/ tablet/ assay Prednisone - basket Prednisone - paddle Sal’c acid - basket Sal’c acid - paddle

Comments  Variability due to the combination of apparatus, tablet, and assay is low, particularly for the basket (Apparatus 1)  Assay variability around 2% CV, so much of the contribution from apparatus/tablet/assay is due to the assay

Determination of Acceptance Ranges  Acceptance range based on sum of the three variances  Intended to represent range of values to be expected from a random tablet tested at a random laboratory using good practice

Issue for Acceptance Ranges  Ranges determined for a single tablet, but applied to sets of 6 and must pass all 6  Possible solutions  Standard statistical multiple testing adjustment; i.e., widen the intervals to 99% from 95%  Allow retesting  Set acceptance ranges on sample mean and standard deviation as done in collaborative study; i.e., would the data qualify for inclusion in the determination of the acceptance range

Topics  Systems Suitability Studies for Dissolution  Collaborative Study Design and Analysis  Variances: Correction to May 2005 Discussion  Next Steps

Calibrator to Control Product Variability  Total product variability, σ 2 total = σ 2 product + σ 2 measurement  σ 2 total for calibrator = σ 2 calibrator + σ 2 C*measurement  Since σ 2 calibrator is not known use σ 2 total for calibrator  σ 2 total for calibrator is given in the acceptable ranges  σ 2 total = σ 2 product + calibrator range Argument against USP RS in dissolution system suitability delivered at various venues

Restating Concerns About Calibrator Variability  This argument does not hold; maybe σ 2 total < σ 2 product + calibrator range  Calibrator variability does not contribute to product variability

Topics  Systems Suitability Studies for Dissolution  Collaborative Study Design and Analysis  Variances: Correction to May 2005 Discussion  Next Steps

Next Steps  Continued work to improve chemical calibration, e.g., approach to avoid ‘multiple testing’  Acknowledge that dissolution is ‘case by case’—resolved with ‘flexible monograph’—differences acceptable if bioequivalent  Assess various approaches to Systems Suitability for the dissolution procedure; e.g., develop methodology to measure fluid flow that is applicable in QC environment (engineering approach)  Setting acceptance criteria for marketed dosage forms (not calibrators): tolerance interval approach based on clinical trial batches (see Hauck et al., Pharmaceutical Research 2005)  USP willing to work with all stakeholders on complex science/technical issues for Performance test; ‘Quality by Design’ approaches should be highly valuable.